Google DeepMind releases AlphaGenome 2 for cell-type variant effects
Original title: Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects
The supplied page contains only a cookie notice, so no model details, availability, or benchmarks are stated.
The item title says Google DeepMind released AlphaGenome 2 for cell-type-specific variant effects. The captured page text is a cookie-consent banner and does not describe the model, its training data, availability, or results. No security issue is stated.
Unconfirmed: Only the title is available; the article body was replaced by cookie-consent text, so the release details are unconfirmed here.
- Organizations
- Google DeepMind
- AI models
- AlphaGenome 2
From the original article
14 min read at marktechpost.comGoogle DeepMind released AlphaGenome 2, a conditional DNA sequence model that predicts regulatory activity and variant effects per cell type. It is available via the AlphaGenome API for non-commercial research. The post Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects appeared first on MarkTechPost.
By Asif Razzaq · marktechpost.com
A short excerpt; the article and its images belong to the publisher. Summary, key facts and assessment above are AI-written from the article and can be wrong.